MTX, methotrexate

Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients
M Cutolo, S Capellino, P Montagna, A Sulli, B Seriolo, B Villaggio

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 728-735; DOI: 10.1136/ard.2005.045641
Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
M H Schiff, G R Burmester, J D Kent, A L Pangan, H Kupper, S B Fitzpatrick, C Donovan

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 889-894; DOI: 10.1136/ard.2005.043166
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
C Antoni, G G Krueger, K de Vlam, C Birbara, A Beutler, C Guzzo, B Zhou, L T Dooley, A Kavanaugh

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1150-1157; DOI: 10.1136/ard.2004.032268
A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment
P Durez, A Nzeusseu Toukap, B R Lauwerys, D H Manicourt, P Verschueren, R Westhovens, J-P Devogelaer, F A Houssiau

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1069-1074; DOI: 10.1136/ard.2003.012914
Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study
T Dervieux, D Furst, D O Lein, R Capps, K Smith, J Caldwell, J Kremer

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1180-1185; DOI: 10.1136/ard.2004.033399
Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study
P L C M van Riel, A J Taggart, J Sany, M Gaubitz, H W Nab, R Pedersen, B Freundlich, D MacPeek

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1478-1483; DOI: 10.1136/ard.2005.043299
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study
M E Weinblatt, E C Keystone, D E Furst, A F Kavanaugh, E K Chartash, O G Segurado

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 753-759; DOI: 10.1136/ard.2005.044404
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis
Bernhard Hellmich, Oliver Flossmann, Wolfgang L Gross, Paul Bacon, Jan Willem Cohen-Tervaert, Loic Guillevin, David Jayne, Alfred Mahr, Peter A Merkel, Heiner Raspe, David G I Scott, James Witter, Hasan Yazici, Raashid A Luqmani

Annals of the Rheumatic Diseases May 2007, 66 (5) 605-617; DOI: 10.1136/ard.2006.062711
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
Gerd R Burmester, Xavier Mariette, Carlomaurizio Montecucco, Indalecio Monteagudo-Sáez, Michel Malaise, Athanasios G Tzioufas, Johannes W J Bijlsma, Kristina Unnebrink, Sonja Kary, Hartmut Kupper

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 732-739; DOI: 10.1136/ard.2006.066761
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
S B Cohen, L W Moreland, J J Cush, M W Greenwald, S Block, W J Shergy, P S Hanrahan, M M Kraishi, A Patel, G Sun, M B Bear

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1062-1068; DOI: 10.1136/ard.2003.016014

Main menu

MTX, methotrexate

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

MTX, methotrexate

Pages